Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors
ExCellThera Inc. and its subsidiary Cordex Biologics announced that Zemcelpro (UM171 Cell Therapy) has received conditional marketing authorization from the European Commission (EC) for…
Read More...
Read More...
